SGHT

Sight Sciences, Inc. SGHT

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,745 of 2,925

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$23.39M

Quarter to Jun 30

Net income

$-4.45M

Quarter to Jun 30

Free cash flow

$-5.68M

Quarter to Jun 30

Operating margin

-16.6%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$118.47M total
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/SGHT

Earnings Per Share

13fpro.ai/company/SGHT

Loading ratio trend…

SGHT key financials by period

Reported revenue, net income and operating margin by fiscal year, from Sight Sciences, Inc.'s annual filings on SEC EDGAR.

Sight Sciences, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$77.4M$-38.4M-47.9%
FY 2024$79.9M$-51.5M-63.3%
FY 2023$81.1M$-55.5M-70.7%
FY 2022$71.3M$-86.2M-117.7%
FY 2021$49.0M$-63.0M-105.2%
FY 2020$27.6M$-34.7M-116.5%
Source: SGHT filings on SEC EDGAR →

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

SGHT insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Sight Sciences, Inc. (SGHT): stock profile, AI score and financials

Sight Sciences, Inc. (SGHT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SGHT at 20.7/100 on a composite quality score built from its SEC filings, placing it at rank #2,745 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (8.7) and free cash flow (12.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 10.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Sight Sciences, Inc. reports quarterly revenue of $23.4M, net income of $-4.4M, an operating margin of -16.6%. Top institutional holders of SGHT by reported 13-F value include Long Focus Capital Management, BlackRock, Americana Partners, based on the most recent SEC filings. SGHT trades on the Nasdaq exchange and files with the SEC under CIK 1531177. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SGHT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Sight Sciences, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1531177 →